Relmada Therapeutics Inc Long-term Investment Intensity

Latest as of March 2018: 6.0%

Relmada Therapeutics Inc long-term investment intensity. Relmada Therapeutics Inc (RLMD) has a Long-term Investment Intensity of 6.0% as of March 2018. Long-term investments of $289.87K represent 6.0% of total assets of $4.80 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read RLMD total liabilities for a breakdown of total debt and financial obligations.

LT Investment Intensity

6.0%
LT Investments / Total Assets

Long-term Investments

$289.87K
USD

Total Assets

$4.80 Million
USD

Country

USA
NASDAQ

Long-term Investment Intensity of Relmada Therapeutics Inc (2016–2016)

Long-term investment intensity of Relmada Therapeutics Inc from 2016 to 2016. This chart shows how Relmada Therapeutics Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2016 to 2016. As of March 2018, the intensity stands at 6.0%, reflecting long-term investments of $289.87K against total assets of $4.80 Million USD.

Relmada Therapeutics Inc Long-term Investment Intensity by Year (2016–2016)

Relmada Therapeutics Inc long-term investment intensity by year from 2016 to 2016. The table below presents the year-by-year Long-term Investment Intensity for Relmada Therapeutics Inc from 2016 to 2016, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see RLMD total asset value.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2016 3.3% $337.73K $10.24 Million —
pp = percentage points